Endothelial-directed hepatic regeneration after partial hepatectomy.
PDF (800K)
+7 authors
Journal: 2003/June - Annals of Surgery
ISSN: 0003-4932
Abstract:
OBJECTIVE
To determine the role of the microvascular endothelium in the regulation of regenerating liver mass after partial hepatectomy.
BACKGROUND
Angiogenesis is critical for both pathologic and physiologic processes. The ability of certain tissues, such as the liver, kidney, and spleen, to regenerate after injury is poorly understood. The liver will regenerate to its normal mass within 8 days of surgical excision. Because the authors have previously shown that the endothelial cell regulates tumor mass, we hypothesized that normal adult organ mass is also controlled by the endothelial cell.
METHODS
Two-thirds partial hepatectomy was performed in 7- to 8-week-old C57 BL/6 mice, followed by systemic treatment with either the angiogenesis stimulator basic fibroblast growth factor (bFGF) (1 microg/g/d intraperitoneal) or the angiogenesis inhibitor TNP-470 (30 mg/kg/qod subcutaneous). Groups of three mice were then euthanized on postoperative days 2, 4, 6, and 8, and the livers were weighed and analyzed by immunohistochemistry.
RESULTS
bFGF accelerated hepatic regeneration by 42%, 19%, 16%, and 16% on postoperative days 2, 4, 6, and 8, respectively. TNP-470 inhibited hepatic regeneration by 46%, 74%, 67%, and 64% on postoperative days 2, 4, 6, and 8, respectively. Immunohistochemistry revealed that bFGF and TNP-470 primarily affected the endothelial compartment. Specifically, bFGF increased endothelial proliferation and decreased endothelial apoptosis. TNP-470, in contrast, inhibited endothelial cell proliferation. The cessation of the regenerative process correlated with a decrease in endothelial proliferation and an increase in endothelial apoptosis.
CONCLUSIONS
The systemic administration of angiogenesis agents modulates the regeneration of hepatic mass primarily by affecting endothelial cell proliferation or apoptosis. Endothelial cell apoptosis is associated with the cessation of the regenerative process in control mice. These results suggest that the endothelial cell is one of the key mediators of regenerating adult tissue mass in this partial hepatectomy model.
Open in
PUBMED | DOI | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(34)
References
(28)
Chemicals
(4)
Organisms
(3)
Processes
(3)
Anatomy
(3)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Ann Surg 237(4): 530-535
PMID: 12677150

Endothelial-Directed Hepatic Regeneration After Partial Hepatectomy

+3 authors
From the Department of *Surgery and
‡Pathology, Children’s Hospital, Harvard Medical School, Boston, Massachusetts;
†Department of Surgery, Henry Ford Health Sciences Center, Detroit, Michigan;
§Cancer Center, Karolinska Hospital, Stockholm, Sweden; and
¶Divisions of Radiation Oncology and Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
Copyright © 2003 Lippincott Williams & Wilkins, Inc.

Abstract

Objective

To determine the role of the microvascular endothelium in the regulation of regenerating liver mass after partial hepatectomy.

Summary Background Data

Angiogenesis is critical for both pathologic and physiologic processes. The ability of certain tissues, such as the liver, kidney, and spleen, to regenerate after injury is poorly understood. The liver will regenerate to its normal mass within 8 days of surgical excision. Because the authors have previously shown that the endothelial cell regulates tumor mass, we hypothesized that normal adult organ mass is also controlled by the endothelial cell.

Methods

Two-thirds partial hepatectomy was performed in 7- to 8-week-old C57 BL/6 mice, followed by systemic treatment with either the angiogenesis stimulator basic fibroblast growth factor (bFGF) (1 μg/g/d intraperitoneal) or the angiogenesis inhibitor TNP-470 (30 mg/kg/qod subcutaneous). Groups of three mice were then euthanized on postoperative days 2, 4, 6, and 8, and the livers were weighed and analyzed by immunohistochemistry.

Results

bFGF accelerated hepatic regeneration by 42%, 19%, 16%, and 16% on postoperative days 2, 4, 6, and 8, respectively. TNP-470 inhibited hepatic regeneration by 46%, 74%, 67%, and 64% on postoperative days 2, 4, 6, and 8, respectively. Immunohistochemistry revealed that bFGF and TNP-470 primarily affected the endothelial compartment. Specifically, bFGF increased endothelial proliferation and decreased endothelial apoptosis. TNP-470, in contrast, inhibited endothelial cell proliferation. The cessation of the regenerative process correlated with a decrease in endothelial proliferation and an increase in endothelial apoptosis.

Conclusions

The systemic administration of angiogenesis agents modulates the regeneration of hepatic mass primarily by affecting endothelial cell proliferation or apoptosis. Endothelial cell apoptosis is associated with the cessation of the regenerative process in control mice. These results suggest that the endothelial cell is one of the key mediators of regenerating adult tissue mass in this partial hepatectomy model.

Abstract

Footnotes

Supported by a Howard Hughes Medical Institute Postdoctoral Research Fellowship (A.K.G.). bFGF was the kind gift of Dr. Judy Abraham (Scios, Sunnyvale, CA). TNP-470 was the kind gift of Takeda Chemical Industries, Ltd. (Deerfield, IL).

Correspondence: Judah Folkman, MD, Department of Surgical Research, Children’s Hospital, Harvard Medical School, 300 Longwood Ave., Hunnewell 103, Boston, MA 02115.

E-mail: judah.folkman@tch.harvard.edu

Accepted for publication September 27, 2002.

Footnotes

References

  • 1. Folkman J. Angiogenesis. In: Braumwald E, ed. Harrison’s textbook of internal medicine. New York: McGraw-Hill, 2001: 517–530.
  • 2. Fausto N. Liver regeneration. Hepatology. 2000; 32: 19–31. [[PubMed]
  • 3. Katz AI, Toback GF, Lindheimer MD. Independence of onset of compensatory kidney growth from changes in renal function. Am J Physiol. 1976; 230: 1067–1071. [[PubMed]
  • 4. Alvarez FE, Greco RS. Regeneration of the spleen after ectopic implantation and partial splenectomy. Arch Surg. 1980; 115: 772–775. [[PubMed]
  • 5. Mulroney SE, Woda C, Johnson M, et al. Gender differences in renal growth and function after uninephrectomy in adult rats. Kidney Int. 1999; 56: 944–53. [[PubMed]
  • 6. Pouche A, Chiodera P, Bosio P, et al. Experimental splenic regeneration. Surg Gynecol Obstet. 1986; 162: 25–29. [[PubMed]
  • 7. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997; 276: 60–65. [[PubMed]
  • 8. O’Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell. 1994; 79: 315–328. [[PubMed]
  • 9. Soutter AD, Ellenbogen J, Folkman J. Splenosis is regulated by a circulating factor. J Ped Surg. 1994; 29: 1076–1079. [[PubMed]
  • 10. Folkman J. Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence [editorial]. Endocrinology. 1998; 139: 441–442. [[PubMed]
  • 11. Rupnick MA, Panigrahy D, Langer R, et al. Adipose tissue mass is controlled by angiogenesis in ob/ob mice. Circulation. 1998; 98 (Suppl): I-455. [PubMed]
  • 12. Ross MA, Sander CM, Kleeb TB, et al. Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver. Hepatology. 2001; 34: 1135–1146. [[PubMed]
  • 13. Shimizu H, Miyazaki M, Wakabayashi Y, et al. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol. 2001; 34: 683–689. [[PubMed]
  • 14. Kraizer Y, Mawasi N, Seagal J. Vascular endothelial growth factor and angiopoietin in liver regeneration. Biochem Biophys Res Commun. 2001; 14: 209–215. [[PubMed]
  • 15. Sato T, El-Assal ON, Ono T. Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver. J Hepatol. 2001; 34: 690–698. [[PubMed]
  • 16. Bucher NL. Liver regeneration: An overview. J Gastroenterol Hepatol. 1991; 6: 615–624. [[PubMed]
  • 17. Assy N, Spira G, Paizi M, et al. Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats. J Hepatol. 1999; 30: 911–915. [[PubMed]
  • 18. Taniguchi E, Sakisaka S, Matsuo K, et al. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem. 2001; 49: 121–129. [[PubMed]
  • 19. Bussolino F, DiRenzo MF, Ziche M, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992; 119: 629–641.
  • 20. Kinoshito T, Hirao S, Matsumoto K, et al. Possible endocrine control by hepatocyte growth factor of liver regeneration after partial hepatectomy. Biochem Biophy Res Comm. 1991; 177: 330–335. [[PubMed]
  • 21. Moulton KS, Heller E, Konerding MA, et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999; 99: 1726–1732. [[PubMed]
  • 22. Barnhill RL, Piepkorn MW, Cochran AJ, et al. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol. 1998; 134: 991–994. [[PubMed]
  • 23. Ma TY, Kikuchi M, Sarfeh IJ, et al. Basic fibroblast growth factor stimulates repair of wounded hepatocyte monolayer: modulatory role of protein kinase A and extracellular matrix. J Lab Clin Med. 1999; 134: 363–371. [[PubMed]
  • 24. Hoffmann B, Paul D. Basic fibroblast growth factor and transforming growth factor-alpha are hepatotrophic mitogens in vitro. J Cell Physiol. 1990; 142: 149–154. [[PubMed]
  • 25. Baruch Y, Shoshany G, Neufeld, G, et al. Basic fibroblast growth factor is hepatotropic for rat liver in regeneration. J Hepatol. 1995; 23: 328–331. [[PubMed]
  • 26. Placidi L, Scott E, De Sousa G, et al. Interspecies variability of TNP-470 metabolism, using primary monkey, rat, and dog cultured hepatocytes. Drug Metab Dispos. 1997; 25: 94–99. [[PubMed]
  • 27. Placidi L, Scott E, Eckoff D, et al. Metabolic drug interactions between angiogenic inhibitor TNP-470 and anticancer agents in primary cultured hepatocytes and microsomes. Can Res. 1995; 55: 3036–3041. [[PubMed]
  • 28. Gervaz P, Scholl G, Padrum V, et al. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470. Liver. 2000; 20: 108–113. [[PubMed]
  • 29. Kusaka M, Sudo K, Matsutani E, et al. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br J Cancer. 1994; 69: 212–216.
  • 30. Modlich U, Kaup F, Augustin HG. Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest. 1996; 74: 771–780. [[PubMed]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.